Global Information
회사소개 | 문의 | 비교리스트

세계의 의약품 포장 시장 예측(-2024년) : 플라스틱병, 블리스터팩, 라벨 및 부속품, 뚜껑 및 마개, 프리필드 시린지, 바이알, 앰플

Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Labels & Accessories, Caps & Closures, Pre-filled Syringes, Vials, Ampoules), Raw Material, Drug Delivery Mode (Oral Drugs, Injectables, IV Drugs), Region - Global Forecast to 2024

리서치사 MarketsandMarkets
발행일 2019년 08월 상품 코드 295766
페이지 정보 영문 161 Pages
가격
US $ 4,950 ₩ 5,982,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 8,037,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,850,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 12,086,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 의약품 포장 시장 예측(-2024년) : 플라스틱병, 블리스터팩, 라벨 및 부속품, 뚜껑 및 마개, 프리필드 시린지, 바이알, 앰플 Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Labels & Accessories, Caps & Closures, Pre-filled Syringes, Vials, Ampoules), Raw Material, Drug Delivery Mode (Oral Drugs, Injectables, IV Drugs), Region - Global Forecast to 2024
발행일 : 2019년 08월 페이지 정보 : 영문 161 Pages

세계의 의약품 포장 시장은 2019년에는 836억 달러, 2024년에는 1,119억 달러로 6.0%의 연평균 성장률(CAGR)로 성장할 전망입니다. 종류별로는 프리필드 시린지가 향후 빠르게 성장할 것으로 생각되며, 원재료별로는 플라스틱 및 폴리머가 최대의 점유율을 차지하고 있습니다. 시장 성장의 주요 요인으로 신흥국에서의 의료 제도 정비, 인구 고령화, 신약 개발, 각국 정부의 제약 산업용 지원책 등을 들 수 있습니다.

세계의 의약품 포장(Pharmaceutical Packaging) 시장에 대해 분석했으며, 시장의 기본 구조와 최신 상황, 주요 시장 성장 촉진·저해요인, 시장 동향 전망(과거 2년간·향후 6년간), 종류별·원재료별·약물 전달 형태별·지역별 상세 동향, 시장 경쟁 상황, 주요 기업 개요 등을 조사했습니다.

제1장 서론

제2장 분석 방법

제3장 주요 요약

제4장 주요 조사 결과

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
      • 신흥국에서 제약 산업의 성장
      • 약물 전달 기기나 블리스터 포장의 수요 증가
      • 기술 진보에 의한 의약품 포장 시장의 성장 촉진
      • 건강 의식 증가와 새로운 규제 기준의 적용
    • 성장 억제요인
      • 규제 정책의 변동에 따른 전체적인 포장 비용 상승
      • 신흥 국가의 액세스 제한과 낮은 인지도
    • 시장 기회
      • 의약품 1차 포장의 수요 증가
      • 신흥국에서 3PL(제3자 물류) 등 서비스의 발전
    • 과제
      • 모조품에 대한 안전 보호 대책
  • Porter's Five Forces 분석

제6장 의약품 포장 시장 : 종류별

  • 서론
  • 플라스틱병
    • 표준형 플라스틱병
    • 플라스틱 투약병
    • 플라스틱 자(단지)
  • 블리스터팩
    • Compartment Packs
    • Wallet Packs
  • 라벨 및 부속품
  • 뚜껑 및 마개
  • 의료용 특수 백
  • 프리필드 시린지
  • 열관리 포장
  • 파우치 및 스트립팩
  • 앰플
  • 바이알
  • 프리필드 흡입기
    • 정량 흡입기
    • 건조 분말 흡입기(DPI)
  • 투약 튜브
    • 복합재제 튜브
    • 플라스틱제 튜브
    • 금속제 압출 튜브
  • 자 및 캐니스터
  • 카트리지
  • 기타

제7장 의약품 포장 시장 : 원재료별

  • 서론
  • 플라스틱 및 폴리머
    • 고밀도 폴리에틸렌(HDPE)
    • 폴리에스테르
    • 폴리프로필렌
    • 저밀도 폴리에틸렌(LDPE)
    • 폴리염화비닐(PVC)
    • 환형 올레핀 공중합체
    • 폴리에틸렌 테레프탈레이트(PET)
  • 종이 및 판지
  • 유리
  • 금속
  • 기타

제8장 의약품 포장 시장 : 약물 전달 형태별

  • 서론
  • 경구
  • 경폐
  • 경피
  • 주사제
  • 국소
  • 경비
  • 안과
  • 정맥주사(IV)
  • 기타

제9장 의약품 포장 시장 : 지역별

  • 서론
  • 북미(미국, 캐나다, 멕시코)
  • 유럽(독일, 프랑스, 이탈리아, 영국, 스페인, 러시아 등)
  • 아시아태평양(중국, 일본, 한국, 인도, 호주 등)
  • 남미(브라질, 아르헨티나 등)
  • 중동 및 아프리카(사우디아라비아, 남아프리카공화국, 이집트 등)

제10장 경쟁 상황

  • 개요
  • 기업 전략의 방향성 : 매핑
    • 선구적 기업
    • 혁신적 기업
    • 활동적 기업
    • 신규 기업
  • 기업간 비교 분석
    • 제품 포트폴리오의 확충도
    • 사업 전략의 우수성
  • 주요 기업의 시장 순위
  • 경쟁 상황과 동향
    • 신제품 발매
    • 투자, 사업 확장
    • 기업 인수합병(M&A)
    • 합의, 사업 협력
    • 합작투자

제11장 기업 개요(사업 개요, 주요 제품, 최근 동향, SWOT 분석, MnM의 견해)

  • BERRY GLOBAL INC.
  • GERRESHEIMER AG
  • AMCOR PLC
  • SCHOTT AG
  • APTARGROUP, INC.
  • BECTON, DICKINSON AND COMPANY
  • CATALENT, INC.
  • NIPRO CORPORATION
  • WEST PHARMACEUTICAL SERVICES, INC.
  • WESTROCK COMPANY
  • 기타
    • ALPLA WERKE ALWIN LEHNER GMBH & CO KG
    • ARDAGH GROUP S. A.
    • CCL INDUSTRIES INC.
    • FRANK NOE EGYPT LTD
    • GAPLAST GMBH
    • LONZA GROUP LTD
    • MONDI GROUP
    • NOLATO AB
    • ORIGIN PHARMA PACKAGING
    • OWENS-ILLINOIS, INC.
    • PAREKHPLAST INDIA LTD.
    • SGD PHARMA
    • SILGAN HOLDINGS INC.
    • STEVANATO GROUP
    • VETTER PHARMA INTERNATIONAL GMBH

제12장 부록

KSM 19.08.23

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • TABLE 1: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 2: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 3: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: PLASTIC BOTTLES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: BLISTER PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: LABELS & ACCESSORIES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: CAPS & CLOSURES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: MEDICAL SPECIALTY BAGS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: PRE-FILLED SYRINGES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: TEMPERATURE-CONTROLLED PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: POUCHES & STRIP PACKS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: AMPOULES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: VIALS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: PRE-FILLED INHALERS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: MEDICATION TUBES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: JARS & CANISTERS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: CARTRIDGES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: OTHERS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: BASIC PACKAGING RAW MATERIAL USED IN PHARMACEUTICAL PACKAGING
  • TABLE 20: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 21: PHARMACEUTICAL PACKAGING MARKET SIZE (RAW MATERIAL), BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: TYPE OF GLASS USED FOR DIFFERENT PACKAGING
  • TABLE 23: PHARMACEUTICAL PACKAGING MARKET (DRUG DELIVERY MODE), BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2017-2024 (USD MILLION)
  • TABLE 25: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 28: NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
  • TABLE 29: US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 30: CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 31: MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 32: EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
  • TABLE 35: GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 36: FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 38: UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 39: SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40: RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 41: REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 42: APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 44: APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
  • TABLE 45: CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 46: JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 47: SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 50: REST OF APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53: SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 62: EGYPT: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 63: REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 64: NEW PRODUCT LAUNCH (2016-2019)
  • TABLE 65: INVESTMENT & EXPANSION (2016-2019)
  • TABLE 66: MERGER & ACQUISITION (2016-2019)
  • TABLE 67: AGREEMENT & COLLABORATION (2016-2019)
  • TABLE 68: JOINT VENTURE (2016-2019)

LIST OF FIGURES

  • FIGURE 1: PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
  • FIGURE 2: PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
  • FIGURE 3: PLASTICS & POLYMERS WAS THE LARGEST RAW MATERIAL SEGMENT FOR PHARMACEUTICAL PACKAGING IN 2018
  • FIGURE 4: PLASTIC BOTTLES TO BE LARGEST TYPE OF PHARMACEUTICAL PACKAGING
  • FIGURE 5: ORAL DRUG DELIVERY TO BE LARGEST DRUG DELIVERY MODE IN PHARMACEUTICAL PACKAGING
  • FIGURE 6: APAC TO BE THE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 7: GROWTH IN DEMAND FOR MEDICINES AND RELATED PACKAGING IN PHARMERGING ECONOMIES TO DRIVE THE MARKET
  • FIGURE 8: PLASTICS & POLYMERS TO BE THE LARGEST RAW MATERIAL SEGMENT IN OVERALL PHARMACEUTICAL PACKAGING
  • FIGURE 9: PLASTIC BOTTLES TO BE THE LARGEST PACKAGING TYPE IN OVERALL PACKAGING MARKET
  • FIGURE 10: ORAL DRUG DELIVERY TO BE THE LARGEST SEGMENT IN OVERALL PACKAGING MARKET
  • FIGURE 11: INDIA TO BE THE FASTEST-GROWING MARKET IN APAC
  • FIGURE 12: PLASTIC BOTTLES ACCOUNTED FOR THE LARGEST MARKET SHARE
  • FIGURE 13: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 14: PORTER'S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 15: PLASTIC BOTTLES ACCOUNT FOR LARGEST SHARE OF OVERALL PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 16: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
  • FIGURE 17: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE (2019-2024)
  • FIGURE 18: PHARMACEUTICAL PACKAGING MARKET IN INDIA WILL REGISTER THE HIGHEST CAGR
  • FIGURE 19: NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
  • FIGURE 20: EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
  • FIGURE 21: APAC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
  • FIGURE 22: COMPANIES ADOPTED EXPANSION, NEW PRODUCT LAUNCH, AND ACQUISITION AS KEY STRATEGIES BETWEEN 2016 AND 2019
  • FIGURE 23: PHARMACEUTICAL PACKAGING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 24: AMCOR: COMPANY SNAPSHOT
  • FIGURE 25: AMCOR : SWOT ANALYSIS
  • FIGURE 26: GERRESHEIMER AG: COMPANY SNAPSHOT
  • FIGURE 27: GERRESHEIMER: SWOT ANALYSIS
  • FIGURE 28: BERRY GLOBAL: COMPANY SNAPSHOT
  • FIGURE 29: BERRY GLOBAL: SWOT ANALYSIS
  • FIGURE 30: SCHOTT: COMPANY SNAPSHOT
  • FIGURE 31: SCHOTT: SWOT ANALYSIS
  • FIGURE 32: APTARGROUP: COMPANY SNAPSHOT 137  
  • FIGURE 33: APTARGROUP: SWOT ANALYSIS
  • FIGURE 34: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 35: CATALENT: COMPANY SNAPSHOT
  • FIGURE 36: NIPRO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
  • FIGURE 38: WESTROCK COMPANY: COMPANY SNAPSHOT

"The pharmaceutical packaging market is projected to register a CAGR of 6.0%, in terms of value, between 2019 and 2024."

The pharmaceutical packaging market is projected to grow from USD 83.6 billion in 2019 to USD 111.9 billion by 2024, at a CAGR of 6.0%. The increasing demand for pharmaceuticals owing to increase in healthcare coverage, growing aging population, and an increase in non-communicable disease in pharmerging economies are the major drivers for the pharmaceutical packaging market.

Another factor driving the pharmaceutical packaging market is the new drug development and government initiatives to promote innovations in the pharmaceutical industry and to enhance the use of generics, in developed countries. However, the strict regulations for pharmaceutical packaging in developed countries such as the US, UK, and Japan lead to increase in overall packaging cost, which collectively restraints the pharmaceutical packaging market.

"Pre-filled syringes segment is expected to be the fastest-growing type for pharmaceutical packaging during the forecast period."

Pre-filled syringes are a replacement for traditional vials and syringes. The prefilled syringes aids to reduce wastage, provide patient compliance by offering self-administered metered dosage. The presence of the properties mentioned above, easy handling, and reduction in breakage failure provided by these syringes, boosts demand for pre-filled syringes. The rise in aging population, increase in non-communicable disease such as diabetes, are driving the demand for pre-filled syringes.

"Plastic & polymers is expected to be the largest raw material used in pharmaceutical packaging during the forecast period."

Plastic & polymers are the major raw material type used for pharmaceutical packaging. Variety of plastics such as HDPE, LDPE, PET, and others are used for pharmaceutical packaging. These are cost-effective raw material with excellent shatter resistance hence reduces loss due to breakage.

Plastic can be easily formed in the required shapes such as vials, bottles, syringes, and others. Also, it can be combined with metals such as aluminum to form laminations for flexible packaging. Presence of these properties acts as the major driver for the use of plastic material in pharmaceutical packaging.

"North America is projected to be the largest pharmaceutical packaging market during the forecast period."

North America was the most promising market for pharmaceutical packaging in 2018 and is expected to be the same during the forecast period. The growing aging population, increased demand for generic drugs, healthcare coverage provided by the government are demanding more pharmaceutical drugs, hence driving the North American pharmaceutical packaging market. Also, technological advancements in drug formulations such as biologics and nutraceuticals are responsible for the high growth of the market.

The market sizes estimated in this study were validated through primary interviews conducted with various industry experts globally.

These primary sources are divided into three categories:

  • By Company Type: Tier I - 25%, Tier II - 50%, and Tier III - 25%
  • By Designation: C Level - 20%, Director Level - 30%, and Others - 50%
  • By Region: North America - 20%, Europe - 30%, APAC - 25%, South America - 15%, and the Middle East & Africa - 10%

The report profiles several leading players of the pharmaceutical packaging market that include: Berry Global Inc. (US), Amcor plc (Australia), AptarGroup, Inc. (US), Gerresheimer AG (Germany), Schott AG (Germany), West Pharmaceutical Services, Inc.(US), Becton, Dickinson And Company (US), Nipro Corporation (Japan), Owens-Illinois, Inc.(US), WestRock Company(US), Alpla Werke Alwin Lehner Gmbh & Co Kg (Austria), Ardagh Group SA(Luxembourg), Stevanato Group (Italy), Catalent Inc. (US), CCL Industries Inc. (Canada), Frank Noe Egypt Ltd (Egypt), Gaplast GmbH (Germany), Lonza Group Ltd (Switzerland), Mondi Group (Austria), Nolato AB (Sweden), Origin Pharma Packaging(UK), Parekhplast India Ltd (India), SGD Pharma (France), Silgan Holdings Inc. (US) and Vetter Pharma International GmbH (Germany). The report also includes detailed information about various growth strategies adopted by these key players to strengthen their position in the pharmaceutical packaging market.

RESEARCH COVERAGE:

The objective of this study is to define, describe, and forecast the pharmaceutical packaging market based on various segmentations and strategically analyze these market segments with respect to individual growth trends, growth prospects, and contribution to the overall pharmaceutical packaging market. In this report, the pharmaceutical packaging market has been segmented based on type, raw material, drug delivery mode, and region.

KEY BENEFITS OF BUYING THE REPORT:

The report is expected to help market leaders/new entrants in the pharmaceutical packaging market in the following ways:

  • 1. This report comprehensively segments the pharmaceutical packaging market and provides the closest approximations for the sizes of different segments and subsegments of the market across different verticals and regions.
  • 2. This report is expected to help stakeholders in obtaining an improved understanding of their competitors and gain insights about their businesses. The competitive landscape section includes detailed information about strategies such as new product developments, merger & acquisition, agreement, and investment & expansion, which were undertaken by various key players to enhance their position in the pharmaceutical packaging market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 ASSUMPTIONS
  • 2.5 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN THE PHARMACEUTICAL PACKAGING MARKET
  • 4.2 PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL
  • 4.3 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
  • 4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE
  • 4.5 PHARMACEUTICAL PACKAGING MARKET, BY REGION
  • 4.6 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET, BY TYPE AND COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing pharmaceutical industry in emerging economies
      • 5.2.1.2 Growing demand for drug delivery devices and blister packaging
      • 5.2.1.3 Technological advancements to contribute to the growth of pharmaceutical packaging
      • 5.2.1.4 Growing health awareness and adoption of new regulatory standards
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing overall packaging costs owing to dynamic

regulatory policies 39

      • 5.2.2.2 Lack of access and awareness in emerging markets
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for primary pharmaceutical packaging
      • 5.2.3.2 Expanding 3PL and other services in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Safeguarding against counterfeit products
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY

6 PHARMACEUTICAL PACKAGING MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 PLASTIC BOTTLES
    • 6.2.1 HIGH DEMAND FOR PLASTIC BOTTLES OWING TO EASY WORKABILITY

AND LIGHTWEIGHT PROPERTY 47

    • 6.2.2 STANDARD PLASTIC BOTTLES
    • 6.2.3 PLASTIC DISPENSING BOTTLES
    • 6.2.4 PLASTIC JARS
  • 6.3 BLISTER PACKS
    • 6.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO

DRIVE THE BLISTER PACKS MARKET 48

    • 6.3.2 COMPARTMENT PACKS
    • 6.3.3 WALLET PACKS
  • 6.4 LABELS & ACCESSORIES
    • 6.4.1 LABELS ARE CRUCIAL IN ENSURING PATIENT-DRUG COMMUNICATION COMPLIANCE
  • 6.5 CAPS & CLOSURES
    • 6.5.1 PLASTIC CAPS & CLOSURES ARE EXPECTED TO WITNESS HIGH

GROWTH DURING THE FORECAST PERIOD 50

  • 6.6 MEDICAL SPECIALTY BAGS
    • 6.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS ARE INCREASING

THE DEMAND FOR SPECIALTY BAGS 50

  • 6.7 PRE-FILLED SYRINGES
    • 6.7.1 HIGHER PATIENT COMPLIANCE AND INCREASING AGING POPULATION

ARE DRIVING THE DEMAND FOR PRE-FILLED SYRINGES 51

  • 6.8 TEMPERATURE-CONTROLLED PACKAGING
    • 6.8.1 INCREASED MANUFACTURING OF SPECIALIZED DRUGS WILL FUEL

THE MARKET FOR TEMPERATURE-CONTROLLED PACKAGING 52

  • 6.9 POUCHES & STRIP PACKS
    • 6.9.1 INCREASING DEMAND FOR STANDUP POUCHES OFFERS GROWTH PROSPECTS FOR PACKAGING MANUFACTURERS
  • 6.10 AMPOULES
    • 6.10.1 MARKET FOR AMPOULES IN DEVELOPING COUNTRIES WITNESSING

A GOOD GROWTH RATE 53

  • 6.11 VIALS
    • 6.11.1 DEMAND FOR VIALS IN DEVELOPED COUNTRIES SLOWING DOWN
  • 6.12 PRE-FILLED INHALERS
    • 6.12.1 HIGHER DEMAND OWING TO INCREASING CASES OF PULMONARY

DISEASES DRIVING THE DEMAND 55

    • 6.12.2 METERED DOSE INHALERS
    • 6.12.3 DRY POWDER INHALERS
  • 6.13 MEDICATION TUBES
    • 6.13.1 EASE OF USE IS DRIVING DEMAND FOR MEDICATION TUBES
    • 6.13.2 COMPOSITE TUBES
    • 6.13.3 ALL-PLASTIC TUBES
    • 6.13.4 COLLAPSIBLE METAL TUBES
  • 6.14 JARS & CANISTERS
    • 6.14.1 CANISTERS HELP EXTEND SHELF-LIFE OF PHARMACEUTICAL PRODUCTS
  • 6.15 CARTRIDGES
    • 6.15.1 INCREASING USE OF PRE-FILLED SYRINGES DRIVING THE DEMAND
  • 6.16 OTHERS

7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

  • 7.1 INTRODUCTION
  • 7.2 PLASTICS & POLYMERS
    • 7.2.1 EXCELLENT SHATTER RESISTANT OF PLASTICS & POLYMERS BOOSTS ITS USE IN PRIMARY PACKAGING
    • 7.2.2 HIGH-DENSITY POLYETHYLENE
    • 7.2.3 POLYESTER
    • 7.2.4 POLYPROPYLENE
    • 7.2.5 LOW-DENSITY POLYETHYLENE
    • 7.2.6 POLYVINYL CHLORIDE
    • 7.2.7 CYCLIC OLEFIN COPOLYMER
    • 7.2.8 POLYETHYLENE TEREPHTHALATE
  • 7.3 PAPER & PAPERBOARDS
    • 7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL THE USE

OF PAPER & PAPERBOARDS 64

  • 7.4 GLASS
    • 7.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS

USE IN PRIMARY PACKAGING 64

  • 7.5 METALS
    • 7.5.1 INCREASING USE OF ALUMINIUM FOR BLISTER PACKAGING TO

BOOST THE MARKET FOR METALS SEGMENT 65

  • 7.6 OTHERS

8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE

  • 8.1 INTRODUCTION
  • 8.2 ORAL DRUG DELIVERY PACKAGING
    • 8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY OWING TO EASE OF USAGE
  • 8.3 PULMONARY DRUG DELIVERY PACKAGING
    • 8.3.1 INCREASING CASES OF LUNG-RELATED DISEASES DRIVING DEMAND
  • 8.4 TRANSDERMAL DRUG DELIVERY PACKAGING
    • 8.4.1 INCREASING SMALL DOSE DRUG USAGE FUELING MARKET FOR TRANSDERMAL DRUG DELIVERY PACKAGING
  • 8.5 INJECTABLE PACKAGING
    • 8.5.1 INJECTABLES OFFER IMPROVED PATIENT COMPLIANCE
  • 8.6 TOPICAL DRUG DELIVERY PACKAGING
    • 8.6.1 PREVALENCE OF SKIN DISEASES DRIVES THE MARKET FOR TOPICAL DRUGS
  • 8.7 NASAL DRUG DELIVERY PACKAGING
    • 8.7.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION PROPELLING

THE USE OF NASAL DRUG SYSTEMS 71

  • 8.8 OCULAR DRUG DELIVERY PACKAGING
    • 8.8.1 INCREASING PREVALENCE OF EYE DISORDERS IN THE AGING POPULATION EXPECTED TO FUEL THE CONSUMPTION OF OCULAR DRUGS PACKAGING
  • 8.9 IV DRUGS DELIVERY PACKAGING
    • 8.9.1 GROWING USE DUE TO IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY DRIVING THE DEMAND
  • 8.10 OTHER DRUGS DELIVERY PACKAGING

9 PHARMACEUTICAL PACKAGING MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US pharmaceutical packaging market has reached new

heights with rapid technological advancements 78

    • 9.2.2 CANADA
      • 9.2.2.1 The country provides a competitive business environment for pharmaceutical packaging manufacturers

    • 9.2.3 MEXICO
      • 9.2.3.1 Government initiatives in the healthcare industry are aiding high demand for pharmaceutical packaging
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Need for advanced drug delivery systems due to the increasing aging population and non-communicable diseases is the main reason for the growth of the pharmaceutical packaging market
    • 9.3.2 FRANCE
      • 9.3.2.1 The demand for generic drugs in the country is growing
    • 9.3.3 ITALY
      • 9.3.3.1 Growing exports of pharmaceuticals have a significant impact

on the market 85

    • 9.3.4 UK
      • 9.3.4.1 Innovations in the pharmaceutical industry are increasing the demand for pharmaceutical packaging
    • 9.3.5 SPAIN
      • 9.3.5.1 Government initiatives in the healthcare sector will boost the

demand for pharmaceutical packaging 87

    • 9.3.6 RUSSIA
      • 9.3.6.1 Government initiatives for domestic production of pharmaceuticals are driving the pharmaceutical packaging market
    • 9.3.7 REST OF EUROPE
  • 9.4 APAC
    • 9.4.1 CHINA
      • 9.4.1.1 The government is investing in R&D with a special focus on biologics and biosimilar drugs
    • 9.4.2 JAPAN
      • 9.4.2.1 The sizeable aging population is increasing the demand for medications
    • 9.4.3 SOUTH KOREA
      • 9.4.3.1 The country has a well-developed healthcare industry and houses major pharmaceuticals manufacturers
    • 9.4.4 INDIA
      • 9.4.4.1 Large domestic consumption of pharmaceuticals and export of generic drugs are driving the pharmaceutical packaging market
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Schemes Such as Medicare and PBS are strengthening the

country's pharmaceutical industry 97

    • 9.4.6 REST OF APAC
  • 9.5 SOUTH AMERICA
    • 9.5.1 BRAZIL
      • 9.5.1.1 Free and universal healthcare services supporting the growth

of the pharmaceutical industry 101

    • 9.5.2 ARGENTINA
      • 9.5.2.1 The population has good access to generic drugs supported

by government initiatives 102

    • 9.5.3 REST OF SOUTH AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 SAUDI ARABIA
      • 9.6.1.1 Wider access to healthcare services is increasing the demand

for pharmaceuticals 106

    • 9.6.2 SOUTH AFRICA
      • 9.6.2.1 A gradual rise in generic drug usage will fuel the pharmaceutical packaging market
    • 9.6.3 EGYPT
      • 9.6.3.1 Increasing domestic production and consumption of pharmaceuticals show potential market growth
    • 9.6.4 REST OF THE MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEWS
  • 10.2 COMPETITIVE LEADERSHIP MAPPING, 2018
    • 10.2.1 VISIONARY LEADERS
    • 10.2.2 INNOVATORS
    • 10.2.3 DYNAMIC DIFFERENTIATORS
    • 10.2.4 EMERGING COMPANIES
  • 10.3 COMPETITIVE BENCHMARKING
    • 10.3.1 STRENGTH OF PRODUCT PORTFOLIO
    • 10.3.2 BUSINESS STRATEGY EXCELLENCE
  • 10.4 MARKET RANKING OF KEY PLAYERS
    • 10.4.1 AMCOR PLC
    • 10.4.2 GERRESHEIMER AG
    • 10.4.3 BERRY GLOBAL INC.
    • 10.4.4 SCHOTT AG
    • 10.4.5 APTARGROUP, INC.
  • 10.5 COMPETITIVE SITUATION & TRENDS
    • 10.5.1 NEW PRODUCT LAUNCH
    • 10.5.2 INVESTMENT & EXPANSION
    • 10.5.3 MERGER & ACQUISITION
    • 10.5.4 AGREEMENT & COLLABORATION
    • 10.5.5 JOINT VENTURE

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1 AMCOR PLC
  • 11.2 GERRESHEIMER AG
  • 11.3 BERRY GLOBAL INC.
  • 11.4 SCHOTT AG
  • 11.5 APTARGROUP, INC.
  • 11.6 BECTON, DICKINSON AND COMPANY
  • 11.7 CATALENT, INC.
  • 11.8 NIPRO CORPORATION
  • 11.9 WEST PHARMACEUTICAL SERVICES, INC.
  • 11.10 WESTROCK COMPANY
  • 11.11 OTHERS
    • 11.11.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
    • 11.11.2 ARDAGH GROUP S. A.
    • 11.11.3 CONSTANTIA
    • 11.11.4 CCL INDUSTRIES INC.
    • 11.11.5 FRANK NOE EGYPT LTD
    • 11.11.6 GAPLAST GMBH
    • 11.11.7 LONZA GROUP LTD
    • 11.11.8 MONDI GROUP
    • 11.11.9 NOLATO AB
    • 11.11.10 ORIGIN PHARMA PACKAGING
    • 11.11.11 OWENS-ILLINOIS, INC.
    • 11.11.12 PAREKHPLAST INDIA LTD.
    • 11.11.13 SGD PHARMA
    • 11.11.14 SILGAN HOLDINGS INC.
    • 11.11.15 STEVANATO GROUP
    • 11.11.16 VETTER PHARMA INTERNATIONAL GMBH

Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q